MindMed Archives | Psychedelic Spotlight

Tag Archive for: MindMed

MindMed: Can the Former Darlings of the Psychedelic Biotech Sector Avoid Collapse?

After MindMed's up-listing, the company has been facing a lot of instability and turbulence in the past few months and years. It has been struggling to establish stability in a sector that is still struggling.

Phase II Study Shows LSD as Effective Treatment for Major Depressive Disorder

Phase II Study Shows LSD Is Effective In Treating Major Depressive Disorder

Research

Data from a Phase 2 clinical trial involving LSD-assisted psychotherapy show LSD as effective treatment for Major Depressive Disorder.

Math Over Myth: Weekly Psychedelic Stocks News Roundup

Business, Stock Reports

Get the latest news on psychedelic stocks Cybin, Numinus, MindMed, ATAI, Mindset, Braxia, Tryp, Irwin Naturals, and Revive

Math Over Myth: September Psychedelic Stock News Roundup

Business, Stock Reports

Track the monthly performance of the psychedelic stock sector with our Math over Myth Stock News Roundup

Math Over Myth: MindMed’s Self Destructive Stock Mission

Business, Stock Reports

Psychedelic stock MindMed enters free fall as news of a private equity offering of common stock spooks retail investors

Math Over Myth: Spotlight on MindMed

Business, Stock Reports

In the latest installment of Math Over Myth we navigate psychedelic stock MindMed’s reverse split with Fibonacci numbers

Psychedelic Stocks: MindMed and atai Slash their Pipelines, Mydecine Collapses

Business, Stock Reports

The psychedelic renaissance hits a rough patch as major companies look to tighten their belts or face total collapse. What’s happening with Psychedelic Stocks?